Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT KinaseDirk A. Heerding, Rakesh Kumar, Elisabeth A. Minthorn et al.|Journal of Medicinal Chemistry|2008Cited by 158
Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding SiteJingsong Yang, Allen Oliff, Nino Campobasso et al.|Chemistry & Biology|2011Cited by 120
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analoguesLata T. Gooljarsingh, Peter J. Tummino, Christine Fernandes et al.|Proceedings of the National Academy of Sciences|2006Cited by 119
Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C KinaseNicholas D. Adams, Dashyant Dhanak, Jerry L. Adams et al.|Journal of Medicinal Chemistry|2010Cited by 111
Binding of TPX2 to Aurora A Alters Substrate and Inhibitor InteractionsKelly Anderson, Zhihong Lai, Jingsong Yang et al.|Biochemistry|2007Cited by 70